COLORADO SPRINGS, Colo.,
Jan. 29, 2015 /PRNewswire/
-- Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company
specializing in cannabis formulation-based drug development and
related consulting, is pleased to issue an update regarding its
subsidiary, Michigan Green Technologies LLC (MGT), and the positive
evolution of the Michigan legal
landscape.
Cannabis Science shares the mission of Michigan Green
Technologies in bringing cannabis-based wellness solutions to the
people of Michigan. MGT is
recognized as the leading resource for Michigan legislative initiatives and
management consulting in respect of cannabinoid-based drug
development, nutraceuticals, food supplements, cosmeceuticals and
food products.
"Michigan leaped forward with
the passage into law of the state's hemp bills. Cannabis
Science is pleased with the strong, professional work of its
Michigan-based operations and that
of its many Michigan
partners. MGT represents an incredible assemblage of highly
qualified individuals -- and the team continues to expand. We
look forward to more legislative progress in Michigan over the next few quarters, as
Michigan's and MGT's business
models mature in a parallel fashion," stated Robert Kane, Director & CFO, Cannabis
Science Inc.
MGT celebrated this month's milestone victory: the passage
of Michigan's hemp bills. House
Bills 5439 and 5440 were put into immediate effect and became
Public Act 547. As the state's legislative environment
continues to mature, the prospects grow for MGT's successful
development and delivery of quality cannabis-based care to patients
in need. Michigan's
progressive, common sense approach to legislation is likely to make
it a leading US state in which cannabis-based care is fully
integrated into the general healthcare system, thus providing
patients with effective products in a safe and regulated
manner.
Other updates include the following:
- MGT continues development in preparation for projects with
various of Michigan's universities
to engage and invest in clinical research and educational
programs;
- MGT progresses in securing a potent and talented advisory board
that encompasses professionals and experts in law, medicine, law
enforcement, state and federal government, and R & D;
- MGT has created a network of county governmental leaders
throughout the state for the purpose of implementation of a
statewide pilot program spanning all aspects of a robust hemp
program, including education of key stakeholders;
- MGT is excited about the future of upcoming initiatives, such
as the Michigan Medical Marihuana Act and related pending
legislation, to rationalize and organize the state's cannabis
program for safe, viable and effective patient care.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique
understanding of metabolic processes to provide novel treatment
approaches to a number of illnesses for which current treatments
and understanding remain unsatisfactory. Cannabinoids have an
extensive history dating back thousands of years, and currently,
there are a growing number of peer-reviewed scientific publications
that document the underlying biochemical pathways that cannabinoids
modulate. The Company works with leading experts in drug
development, medicinal characterization, and clinical research to
develop, produce, and commercialize novel therapeutic approaches
for the treatment for illnesses caused by infections as well as for
age-related illness. Our initial focus is on skin cancers and
neurological conditions.
Forward-Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
words such as "anticipate," "seek," intend," "believe," "estimate,"
"expect," "project," "plan," or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events
or results anticipated by these forward-looking statements may not
occur. Factors that could cause or contribute to such differences
include the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations
regarding the use and development of cannabis-based drugs. Cannabis
Science, Inc., does not undertake any duty nor does it intend to
update the results of these forward-looking statements.
Cannabis Science, Inc
Raymond C. Dabney
Director, President & CEO, Co-Founder
raymond@cannabisscience.com
Tel: 1.310.650.3788
Chad S. Johnson, Esq.
Director, COO & General Counsel
www.cannabisscience.com
info@cannabisscience.com
Tel: 1.888.777.0658
Robert Kane,
Director & CFO
www.cannabisscience.com
info@cannabisscience.com
Tel: 1.888.777.0658
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cannabis-science-cbis-issues-upbeat-report-on-its-subsidiary-michigan-green-technologies-mgt-as-historic-michigan-milestone-is-reached-with-new-hemp-legislation-300027887.html
SOURCE Cannabis Science, Inc.